The fund seeks long term growth.
Name | % Net Assets |
---|---|
BP | 5.8% |
Royal Dutch Shell 'B' | 5.6% |
HSBC | 4.2% |
GlaxoSmithKline | 3.9% |
Vodafone | 3.9% |
AstraZeneca | 3.8% |
Centrica | 3.5% |
Mothercare | 3.4% |
Aviva | 3.0% |
National Grid | 2.9% |
Key | % Net Assets |
---|---|
BP | 5.8% |
Royal Dutch Shell 'B' | 5.6% |
HSBC | 4.2% |
GlaxoSmithKline | 3.9% |
Other | 80.5% |
Date | 18-Apr-2024 |
---|---|
NAV | 225.85p |
Currency | GBP |
Change | -0.79p |
% | -0.35% |
YTD change | -3.54p |
YTD % | -1.54% |
Fund Inception | 09/05/2006 |
---|---|
Fund Manager | SRI Team and Pan-European Equities Team |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research